MN 580 MIDTERM ACTUAL EXAM PAPER
2026 QUESTIONS WITH ANSWERS GRADED
A+
• Epidemiology of Trachoma.
Answer: - half of active cases occur in five countries: Ethiopia, India,
Nigeria, Sudan, Guinea - highest prevalence in sub-Saharan Africa - its
complications described in 27th century BC China and 19th century BC
Egypt - 2.2 million visual impairment from trachoma - 1.2 million
irreversible blindness - 103 million people live in areas where trachoma
remains a risk
• T/F: Toxin ELISA is highly sensitive and therefore rarely produces false
negatives.
Answer: False
• methodology.
Answer: is the method appropriate for problem being studied? is the sample
studied representative of the population of interest? random sampling should
be used has the method of sample selection been identified? is the sample
size appropriate for the research question? are the data collection
instruments described? are the data collection instruments appropriate for
the research questions (and the population)? are the instruments reliable and
valid? have the psychometrics been included? (psychometrics deal with the
theory and development of measurement instruments--should always be
included b/c tell you what patient population the instruments have been used
on and what their reliability and validity are) is the design internally valid?
• Rift Valley Fever Basics.
Answer: -Bunyaviridae (Phenuiviridae genus) - East Africa, West Africa,
Middle East - Infects cattle, goats, and humans - Mosquito-borne (Aedes
mosquitoes, Culex mosquitoes) - no human-to-human transmission
,• MASCC Index for determining severity of neutropenic fever treatment.
Answer: used to determine risk of severe complications from neutropenic
fever; guides outpatient or inpatient treatment low risk (treat outpatient):
>21 points high risk (admit inpatient): <21 points
• Patient centeredness.
Answer: satisfying patients' needs and wants. - patients' wants can only be
known if patients are asked or express them - care should serve patients'
interests as defined by the patients themselves
• placebo.
Answer: concurrent, second group that is treated identically, but receives a
placebo rather than the active drug
• designing your own survey.
Answer: white space: the more white space you have on your survey, the
more user friendly it appears font: make it easy to read (no fancy fonts)
boxes vs. lines: if you're asking a question on someone's age and you're
giving them options (<17, >18, etc.), it's recommended that the line be
turned into a box so the response is clearly associated with the response
you're interested in (in a line, sometimes people make big checks and it's
hard to figure out which one they were actually checking) questions order:
can present information in earlier questions and then ask the subject an
information question later on when you've already answered their question
previously biased questions: avoid negative items: people tend to
overlook/ignore things like "not" or "none" or a double negative relevance
of each question: to what you're interested in--each question should address
the topic of interest clarity of questions
• CML treatment.
Answer: -chemo -bone marrow transplant only curative therapy
• a client is displaying low self esteem poor self control self doubt and a high
level of dependency these behaviors indicate developmental failure of which
of the following stages of development?`.
Answer: early childhood
, • randomization.
Answer: random assignment, random selection, random allocation what
investigator does to subjects to split them into groups:
experimental/manipulated group vs. control group occurs after you have
already obtained your sample population assignment of treatment(s) to
groups such that each subject has equal and independent chance of being
selected (included) in a sample randomization does NOT ensure equal
distribution of characteristics betwen treatment groups ethical only if
research subjects can safely receive any of the treatment choices
• partial agonist.
Answer: stabilizers stable solution between too much full agonist and no
action at all
• binge eating disorder.
Answer: significant binge-eating episodes, followed by distress, disgust, or
guilt, but without the compensatory purging, fasting, or excessive exercise
that marks bulimia nervosa
• appraising the evidence of physiologic measurement.
Answer: is the instrument used appropriate to the problem? is the rationale
provided for instrument selection? is there a provision for evaluation of the
accuracy of the instrument?
• 3. Defined membership.
Answer: - Clear understanding of who is on the team - Membership may
change over time but is clear at any moment
• non-experimental designs.
Answer: process of exploring relationships, common themes in a
population--not trying to establish a cause and effect--no manipulation of
variables--all non-experimental designs are descriptive surveys
observational studies correlational studies cross sectional longitudinal ex
post facto methodologic simulation
• Midterm 2.
2026 QUESTIONS WITH ANSWERS GRADED
A+
• Epidemiology of Trachoma.
Answer: - half of active cases occur in five countries: Ethiopia, India,
Nigeria, Sudan, Guinea - highest prevalence in sub-Saharan Africa - its
complications described in 27th century BC China and 19th century BC
Egypt - 2.2 million visual impairment from trachoma - 1.2 million
irreversible blindness - 103 million people live in areas where trachoma
remains a risk
• T/F: Toxin ELISA is highly sensitive and therefore rarely produces false
negatives.
Answer: False
• methodology.
Answer: is the method appropriate for problem being studied? is the sample
studied representative of the population of interest? random sampling should
be used has the method of sample selection been identified? is the sample
size appropriate for the research question? are the data collection
instruments described? are the data collection instruments appropriate for
the research questions (and the population)? are the instruments reliable and
valid? have the psychometrics been included? (psychometrics deal with the
theory and development of measurement instruments--should always be
included b/c tell you what patient population the instruments have been used
on and what their reliability and validity are) is the design internally valid?
• Rift Valley Fever Basics.
Answer: -Bunyaviridae (Phenuiviridae genus) - East Africa, West Africa,
Middle East - Infects cattle, goats, and humans - Mosquito-borne (Aedes
mosquitoes, Culex mosquitoes) - no human-to-human transmission
,• MASCC Index for determining severity of neutropenic fever treatment.
Answer: used to determine risk of severe complications from neutropenic
fever; guides outpatient or inpatient treatment low risk (treat outpatient):
>21 points high risk (admit inpatient): <21 points
• Patient centeredness.
Answer: satisfying patients' needs and wants. - patients' wants can only be
known if patients are asked or express them - care should serve patients'
interests as defined by the patients themselves
• placebo.
Answer: concurrent, second group that is treated identically, but receives a
placebo rather than the active drug
• designing your own survey.
Answer: white space: the more white space you have on your survey, the
more user friendly it appears font: make it easy to read (no fancy fonts)
boxes vs. lines: if you're asking a question on someone's age and you're
giving them options (<17, >18, etc.), it's recommended that the line be
turned into a box so the response is clearly associated with the response
you're interested in (in a line, sometimes people make big checks and it's
hard to figure out which one they were actually checking) questions order:
can present information in earlier questions and then ask the subject an
information question later on when you've already answered their question
previously biased questions: avoid negative items: people tend to
overlook/ignore things like "not" or "none" or a double negative relevance
of each question: to what you're interested in--each question should address
the topic of interest clarity of questions
• CML treatment.
Answer: -chemo -bone marrow transplant only curative therapy
• a client is displaying low self esteem poor self control self doubt and a high
level of dependency these behaviors indicate developmental failure of which
of the following stages of development?`.
Answer: early childhood
, • randomization.
Answer: random assignment, random selection, random allocation what
investigator does to subjects to split them into groups:
experimental/manipulated group vs. control group occurs after you have
already obtained your sample population assignment of treatment(s) to
groups such that each subject has equal and independent chance of being
selected (included) in a sample randomization does NOT ensure equal
distribution of characteristics betwen treatment groups ethical only if
research subjects can safely receive any of the treatment choices
• partial agonist.
Answer: stabilizers stable solution between too much full agonist and no
action at all
• binge eating disorder.
Answer: significant binge-eating episodes, followed by distress, disgust, or
guilt, but without the compensatory purging, fasting, or excessive exercise
that marks bulimia nervosa
• appraising the evidence of physiologic measurement.
Answer: is the instrument used appropriate to the problem? is the rationale
provided for instrument selection? is there a provision for evaluation of the
accuracy of the instrument?
• 3. Defined membership.
Answer: - Clear understanding of who is on the team - Membership may
change over time but is clear at any moment
• non-experimental designs.
Answer: process of exploring relationships, common themes in a
population--not trying to establish a cause and effect--no manipulation of
variables--all non-experimental designs are descriptive surveys
observational studies correlational studies cross sectional longitudinal ex
post facto methodologic simulation
• Midterm 2.
